Manuelle Debunne

Provided development strategy and fundraising consulting for biotech companies, including competitive positioning, investor narrative, and licensing readiness. Reviewed scientific and clinical data packages to support partnership and investment decisions.

Led company operations, including strategy execution, pipeline management, and Board-level reporting. Managed sponsor and CRO relationships and drove £4.2M fundraising across two tranches to advance a molecule to clinical candidate.

Conducted scientific due diligence for oncology assets available for licensing, coordinating cross-functional assessments and authoring recommendation reports. Led spinout creation (including Nodus Oncology and Nuan Bioscience) by building development plans and fundraising materials, while coordinating CRO activities for preclinical execution.

Performed market opportunity assessments and due diligence for a novel oral bioavailability technology. Engaged investors and industry stakeholders to prepare presentations supporting match funding alongside a regional grant.

Assessed market opportunities across therapeutic, device, and diagnostic innovations to identify highest-value assets. Developed business plans and investor presentations and managed translational research funding applications through stakeholder engagement with pharma, VCs, incubators, and government agencies.

Created and managed core mAb development plans, aligning R&D activities with commercialisation goals and IP protection. Managed CRO contracts and interdisciplinary recruitment, and secured £200,000 via SMART:Scotland funding.

Led market research and product positioning for oncology and autoimmune assets. Produced investor materials supporting a £2M fundraising campaign and managed CRO interactions to inform strategic development planning.

Managed £2.2M grant funding (Wellcome Trust + MRC) for development of five molecular imaging tools. Set up a first-in-human clinical trial for a novel neutrophil-activated probe (NAP).

Earned PRINCE2 Practitioner certification in 2013 for project management.

Completed executive education in Entrepreneurship & Business at Babson College from 2013 to 2014.

Completed Clinical Research Associate certification covering GCP, GMP, and clinical trials monitoring in 2012.

PhD in Pharmacology & Cardiovascular Physiopathology at the University of Rouen from 2006 to 2009.